Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-10 Purchase |
2023-03-14 4:12 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) |
View |
| 2023-03-10 Purchase |
2023-03-14 4:09 pm |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) |
View |
| 2023-02-08 Purchase |
2023-02-10 4:32 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) |
View |
| 2023-02-08 Purchase |
2023-02-10 4:22 pm |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:25 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:21 pm |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) |
View |
| 2023-01-17 Purchase |
2023-01-19 4:18 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) |
View |
| 2023-01-17 Purchase |
2023-01-19 4:13 pm |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) |
View |
| 2022-11-21 Purchase |
2022-12-09 7:59 pm |
Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director |
230,769 | $2.6 | $599,999 | 564,101 (Indirect Direct) |
View |
| 2022-11-17 Purchase |
2022-11-25 7:05 pm |
Tenaya Therapeutics Inc. | TNYA | Casdin Eli Casdin Capital LLC Director |
2,492,042 | $2.6 | $6,479,309 | 7,432,971 (Indirect) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:12 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:11 pm |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) |
View |
| 2022-04-26 Sale |
2022-04-28 7:57 pm |
Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer |
1,353 | $10.13 | $13,706 | 198,646 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-09 Option Award |
2023-06-12 8:34 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:30 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:24 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:17 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Lee June Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:14 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:10 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | CHEN JIN-LONG Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:09 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director |
14,766 | $0 | 14,766 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:48 pm |
2023-03-15 2033-02-14 |
Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer |
205,000 | $0 | 433,646 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:47 pm |
2023-03-15 2033-02-14 |
Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer |
285,000 | $0 | 285,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:45 pm |
2023-03-15 2033-02-14 |
Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer |
255,000 | $0 | 257,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:43 pm |
2023-03-15 2033-02-14 |
Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2022-12-05 Option Award |
2022-12-07 6:20 pm |
2023-01-05 2032-12-04 |
Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-09-08 Option Award |
2022-09-09 7:25 pm |
2023-09-08 2032-09-07 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 9:02 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Walsh Jeffrey T. Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:59 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:58 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:56 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Lee June Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:52 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:49 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | CHEN JIN-LONG Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:45 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Casdin Eli Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 8:41 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Williams R Sanders Director |
39,727 | $0 | 39,727 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:45 pm |
2022-03-15 2032-02-14 |
Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer |
401,390 | $0 | 401,390 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:41 pm |
2022-03-15 2032-02-14 |
Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer |
66,000 | $0 | 66,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:38 pm |
2022-03-15 2032-02-14 |
Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer |
141,000 | $0 | 141,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:36 pm |
2022-03-15 2032-02-14 |
Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer |
168,000 | $0 | 168,000 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-23 5:58 pm |
N/A 2031-12-22 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
19,495 | $0 | 19,495 (Direct) |
View |